All analyses
AI analysis

HNB Life PLC: research report

Moderately undervaluedneutralOct 31, 2026

Evidence is mixed, leaving HNB Life neutral despite a moderately undervalued starting band: September revenue grew 23.9% while profit fell 35.9%. The latest net margin was its weakest September result on record.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why balanced

  • September revenue rose 23.9% year-on-year, maintaining strong top-line momentum.
  • HNB Life reported LKR 434 million of first-half profit after tax on 7 August, alongside 43% growth in life gross written premium.

Against this. September-quarter net profit fell 35.9% to LKR 178 million and the 1.6% net margin was the worst among seven comparable September quarters.

Net margin
1.6%sector 1.4%
from 3.2% a year earlier, revenue +23.9%
Return on equity
17.8%
twelve months to Sep 30, 2026, unaudited
P/E
8.7sector 15.6
earnings Rs 15.73 per share, year to Sep 2026
P/B
1.54sector 1.46
book Rs 88.20 per share
Dividend yield
3.67%sector 1.83%
31.8% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Oct 31, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

HNB Life operates life insurance and general insurance businesses in Sri Lanka through agency, bancassurance and alternate distribution channels. September-quarter revenue expanded strongly but the profit conversion weakened sharply, leaving the assessment neutral relative to the moderately undervalued valuation starting point.

Price performance

The share closed at LKR 134.00 on 30 October 2026. It fell 10.7% over three months while the ASPI fell 4.7%, although its 12.6% one-year gain contrasts with an 11.6% decline in the index. The price sat 64.2% of the way from its 52-week low to high, while recent volatility and trading volume were both below this share's own recent norms.

The three-year record contains two falls of 15% or more, with the deepest at 23% and taking six months to recover. Liquidity is limited: median daily turnover was LKR 639,000, and a LKR 1 million order is more than everything that trades on a typical day, at 157% of it. That makes a LKR 1 million transaction a large part of a normal session.

Valuation

At 8.46 times P/E, the price represents LKR 8.46 paid for every LKR 1 of trailing profit, placing it at the 25th percentile among insurance peers with reported P/E ratios. The 1.52 times P/B means paying LKR 1.52 for each LKR 1 of net assets, but this is at the 70th sector percentile, a premium to the sector's median book multiple.

The share is more expensive than 84% of days since January 2019 on P/E and more expensive than 90% of days on P/B. A buyer at this price is relying mainly on earnings outside the latest quarter: September supplied only 7.6% of trailing EPS, and the P/E would be 7.9 times rather than 8.5 times had that quarter retained its year-ago margin.

The 3.7% trailing dividend yield is based on LKR 5.00 per share for FY2025, up from LKR 3.90 in each of the prior two years. The LKR 5.00 dividend's ex-date was 31 March 2026, so a buyer today does not receive it.

News and sentiment

Direct coverage was normal, with two material articles in the past 90 days, both positive and none negative. On 7 August, the company reported 43% growth in first-half life gross written premium to LKR 12.34 billion and LKR 434 million of profit after tax.

Board and management appointments at HNB General Insurance were also reported during the period, including a new chief operating officer and two director appointments. These are governance and operating changes rather than quantified earnings events.

Financials

September-quarter revenue rose 23.9% year-on-year to LKR 10.9 billion, but net profit fell 35.9% to LKR 178 million. Revenue grew while the profit available to shareholders shrank, meaning the additional business generated less profit in the quarter.

Gross and operating margins were not supplied for either September quarter. Net margin fell from 3.1% to 1.6%, and was the worst of seven comparable September quarters on record. This is a like-for-like group-basis comparison and shows that the quarter retained less than two cents of profit for every rupee of reported revenue.

The latest audited full year was FY2025, when return on equity was 16.9%. Equity was LKR 13.2 billion at September 2026 versus LKR 12.9 billion a year earlier, while the share count remained unchanged at 150 million, so the quarterly earnings movement was not mechanically diluted by a share issue.

Risks

The principal balance-sheet risk is the insurer's liability base relative to equity. Total liabilities were 4.71 times equity at FY2025, up from 3.99 times a year earlier. For every rupee of equity, the group carried LKR 4.71 of liabilities, making the quality and valuation of insurance liabilities and investment assets particularly important.

The September profit decline is the immediate operating risk because revenue growth did not convert into comparable earnings. Insurance-sector conditions also include rising and volatile bond yields and a softer rupee, which can affect insurers' fixed-income portfolio valuations, reinvestment returns and foreign-currency reinsurance costs.

Outlook

As at 31 October 2026, the next defined catalyst is the audited year to 31 December 2026, expected to be filed between 28 April and 3 June 2027. It will replace the September-quarter view and establish whether the weak profit conversion was confined to that quarter or persisted through the year.

The available data cannot separate the drivers of September's profit decline because operating profit and below-the-line movements were not supplied for that quarter. The annual filing is therefore the next evidence point for assessing earnings quality alongside the insurer's liability and investment position.

About this report. Generated on Oct 31, 2026 from market data up to Oct 30, 2026, 2 material news articles over 90 days and financials to Sep 30, 2026, and scored 70 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports